Nordson Corporation Reports Record First Quarter Fiscal 2026 Results and Increases Full Year Guidance
First Quarter Highlights:
-
Sales were a first quarter record of
$669 million , an increase of 9% year-over-year -
Earnings per diluted share were
$2.38 , up 44% year-over-year -
Adjusted earnings per diluted share were
$2.37 , a first quarter record and up 15% year-over-year - Backlog grew approximately 4% year-over-year
- Increasing full year guidance for sales and earnings
Net income was
EBITDA was also a first quarter record of
Commenting on the Company’s fiscal 2026 first quarter results, Nordson President and Chief Executive Officer
First Quarter Segment Results
Industrial
Medical and Fluid Solutions sales of
Outlook
The Company enters the second quarter with increased backlog, up approximately 4% over the prior year. Order entry momentum was broad-based in the quarter with particular strength in our ATS segment. These trends position the Company to deliver second quarter fiscal 2026 sales in the range of
Based on the strong start to the year, the second quarter outlook and the current foreign exchange rate environment, the Company is increasing its full year guidance. Sales are now expected to be in the range of
Reflecting on the full year outlook,
Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on
Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to,
|
SEGMENT INFORMATION (Unaudited) (Dollars in thousands)
|
|||||||||||||
|
|
Three Months Ended |
||||||||||||
|
|
|
|
|
||||||||||
|
SALES |
|
|
|
|
|
|
|
||||||
|
Industrial |
$ |
326,861 |
|
|
|
|
$ |
300,448 |
|
|
|
||
|
Medical and Fluid Solutions |
|
193,183 |
|
|
|
|
|
193,609 |
|
|
|
||
|
|
|
149,417 |
|
|
|
|
|
121,363 |
|
|
|
||
|
Total sales |
$ |
669,461 |
|
|
|
|
$ |
615,420 |
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
EBITDA |
|
|
|
|
|
|
|
||||||
|
Industrial |
$ |
110,311 |
|
|
34 |
% |
|
$ |
112,776 |
|
|
38 |
% |
|
Medical and Fluid Solutions |
|
70,206 |
|
|
36 |
% |
|
|
64,332 |
|
|
33 |
% |
|
|
|
32,600 |
|
|
22 |
% |
|
|
22,771 |
|
|
19 |
% |
|
Corporate expenses |
|
(10,127 |
) |
|
|
|
|
(11,776 |
) |
|
|
||
|
Total EBITDA (non-GAAP) (1) |
$ |
202,990 |
|
|
30 |
% |
|
$ |
188,103 |
|
|
31 |
% |
|
(1) |
Total company EBITDA is a non-GAAP measure. Refer to the reconciliation of non-GAAP measures – net income to EBITDA. |
|
CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (Dollars in thousands except for per-share amounts)
|
|||||||
|
|
Three Months Ended |
||||||
|
|
|
|
|
||||
|
Sales |
$ |
669,461 |
|
|
$ |
615,420 |
|
|
Cost of sales |
|
303,339 |
|
|
|
279,524 |
|
|
Gross profit |
|
366,122 |
|
|
|
335,896 |
|
|
Gross margin % |
|
54.7 |
% |
|
|
54.6 |
% |
|
|
|
|
|
||||
|
Selling and administrative expenses |
|
199,717 |
|
|
|
194,949 |
|
|
Operating profit |
|
166,405 |
|
|
|
140,947 |
|
|
|
|
|
|
||||
|
Interest expense — net |
|
(22,741 |
) |
|
|
(25,618 |
) |
|
Other income — net |
|
20,837 |
|
|
|
1,526 |
|
|
Income before income taxes |
|
164,501 |
|
|
|
116,855 |
|
|
|
|
|
|
||||
|
Income taxes |
|
31,119 |
|
|
|
22,203 |
|
|
|
|
|
|
||||
|
Net income |
$ |
133,382 |
|
|
$ |
94,652 |
|
|
|
|
|
|
||||
|
Weighted-average common shares outstanding: |
|
|
|
||||
|
Basic |
|
55,789 |
|
|
|
57,129 |
|
|
Diluted |
|
56,127 |
|
|
|
57,486 |
|
|
|
|
|
|
||||
|
Earnings per share: |
|
|
|
||||
|
Basic earnings |
$ |
2.39 |
|
|
$ |
1.66 |
|
|
Diluted earnings |
$ |
2.38 |
|
|
$ |
1.65 |
|
|
CONSOLIDATED BALANCE SHEETS (Unaudited) (Dollars in thousands)
|
|||||||
|
|
|
|
|
||||
|
Cash and cash equivalents |
$ |
120,392 |
|
$ |
108,442 |
||
|
Receivables — net |
|
571,583 |
|
|
|
587,843 |
|
|
Inventories — net |
|
451,138 |
|
|
|
444,814 |
|
|
Other current assets |
|
108,558 |
|
|
|
101,752 |
|
|
Total current assets |
|
1,251,671 |
|
|
|
1,242,851 |
|
|
|
|
|
|
||||
|
Property, plant and equipment - net |
|
521,508 |
|
|
|
516,914 |
|
|
|
|
3,332,244 |
|
|
|
3,304,685 |
|
|
Other assets |
|
855,499 |
|
|
|
853,231 |
|
|
|
$ |
5,960,922 |
|
|
$ |
5,917,681 |
|
|
|
|
|
|
||||
|
Notes payable and debt due within one year |
$ |
54,312 |
|
|
$ |
315,000 |
|
|
Accounts payable and accrued liabilities |
|
405,737 |
|
|
|
443,260 |
|
|
Total current liabilities |
|
460,049 |
|
|
|
758,260 |
|
|
|
|
|
|
||||
|
Long-term debt |
|
1,943,182 |
|
|
|
1,681,254 |
|
|
Other liabilities |
|
445,585 |
|
|
|
434,596 |
|
|
Total shareholders' equity |
|
3,112,106 |
|
|
|
3,043,571 |
|
|
|
$ |
5,960,922 |
|
|
$ |
5,917,681 |
|
|
|
|
|
|
||||
|
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (Dollars in thousands)
|
|||||||
|
|
Three Months Ended |
||||||
|
|
|
|
|
||||
|
Cash flows from operating activities: |
|
|
|
||||
|
Net income |
$ |
133,382 |
|
|
$ |
94,652 |
|
|
Depreciation and amortization |
|
36,585 |
|
|
|
37,031 |
|
|
Other non-cash items |
|
(11,675 |
) |
|
|
3,160 |
|
|
Changes in operating assets and liabilities and other |
|
(17,864 |
) |
|
|
24,279 |
|
|
Net cash provided by operating activities |
|
140,428 |
|
|
|
159,122 |
|
|
|
|
|
|
||||
|
Cash flows from investing activities: |
|
|
|
||||
|
Additions to property, plant and equipment |
|
(17,513 |
) |
|
|
(21,399 |
) |
|
Other — net |
|
(158 |
) |
|
|
7,123 |
|
|
Net cash used in investing activities |
|
(17,671 |
) |
|
|
(14,276 |
) |
|
|
|
|
|
||||
|
Cash flows from financing activities: |
|
|
|
||||
|
Issuance (repayment) of long-term debt |
|
2,367 |
|
|
|
(22,563 |
) |
|
Repayment of finance lease obligations |
|
(1,616 |
) |
|
|
(1,320 |
) |
|
Dividends paid |
|
(45,786 |
) |
|
|
(44,602 |
) |
|
Issuance of common shares |
|
18,795 |
|
|
|
1,001 |
|
|
Purchase of treasury shares |
|
(86,001 |
) |
|
|
(60,098 |
) |
|
Net cash used in financing activities |
|
(112,241 |
) |
|
|
(127,582 |
) |
|
|
|
|
|
||||
|
Effect of exchange rate change on cash: |
|
1,434 |
|
|
|
(2,792 |
) |
|
Net change in cash and cash equivalents |
|
11,950 |
|
|
|
14,472 |
|
|
|
|
|
|
||||
|
Cash and cash equivalents: |
|
|
|
||||
|
Beginning of period |
|
108,442 |
|
|
|
115,952 |
|
|
End of period |
$ |
120,392 |
|
|
$ |
130,424 |
|
|
|
|
|
|
||||
|
SALES BY GEOGRAPHIC SEGMENT (Unaudited) (Dollars in thousands)
|
|||||||||||||||||||
|
|
Three Months Ended |
|
Sales Variance |
||||||||||||||||
|
|
2026 |
|
2025 |
|
Organic |
|
Acquisitions / Divestitures |
|
Currency |
|
Total |
||||||||
|
SALES BY SEGMENT |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Industrial |
$ |
326,861 |
|
$ |
300,448 |
|
3.2 |
% |
|
— |
% |
|
5.6 |
% |
|
8.8 |
% |
||
|
Medical and Fluid Solutions |
|
193,183 |
|
|
|
193,609 |
|
|
2.7 |
% |
|
(4.3 |
)% |
|
1.4 |
% |
|
(0.2 |
)% |
|
|
|
149,417 |
|
|
|
121,363 |
|
|
20.7 |
% |
|
— |
% |
|
2.4 |
% |
|
23.1 |
% |
|
Total sales |
$ |
669,461 |
|
|
$ |
615,420 |
|
|
6.5 |
% |
|
(1.4 |
)% |
|
3.7 |
% |
|
8.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
SALES BY GEOGRAPHIC REGION |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
$ |
261,930 |
|
|
$ |
267,836 |
|
|
(0.4 |
)% |
|
(2.9 |
)% |
|
1.1 |
% |
|
(2.2 |
)% |
|
|
|
182,461 |
|
|
|
167,762 |
|
|
(0.3 |
)% |
|
(0.2 |
)% |
|
9.3 |
% |
|
8.8 |
% |
|
|
|
225,070 |
|
|
|
179,822 |
|
|
23.2 |
% |
|
— |
% |
|
2.0 |
% |
|
25.2 |
% |
|
Total sales |
$ |
669,461 |
|
|
$ |
615,420 |
|
|
6.5 |
% |
|
(1.4 |
)% |
|
3.7 |
% |
|
8.8 |
% |
|
RECONCILIATION OF NON-GAAP MEASURES - NET INCOME TO EBITDA (Unaudited) (Dollars in thousands)
|
|||||||
|
|
Three Months Ended |
||||||
|
|
|
|
|
||||
|
Net income |
$ |
133,382 |
|
|
$ |
94,652 |
|
|
Income taxes |
|
31,119 |
|
|
|
22,203 |
|
|
Interest expense — net |
|
22,741 |
|
|
|
25,618 |
|
|
Other income — net |
|
(20,837 |
) |
|
|
(1,526 |
) |
|
Inventory step-up amortization (1) |
|
— |
|
|
|
3,135 |
|
|
Severance and other (1) |
|
— |
|
|
|
5,961 |
|
|
Acquisition-related costs (1) |
|
— |
|
|
|
1,030 |
|
|
Adjusted operating profit |
|
166,405 |
|
|
|
151,073 |
|
|
Depreciation and amortization |
|
36,585 |
|
|
|
37,030 |
|
|
EBITDA (non-GAAP) (2) |
$ |
202,990 |
|
|
$ |
188,103 |
|
|
(1) |
Represents non-recurring cost reduction actions as well as fees and non-cash inventory charges associated with acquisitions. |
|
(2) |
EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as non-recurring cost reduction actions, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization. |
|
RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE (Unaudited) (Dollars in thousands)
|
|||||||
|
|
Three Months Ended |
||||||
|
|
|
|
|
||||
|
GAAP AS REPORTED |
|
|
|
||||
|
Net income |
$ |
133,382 |
|
|
$ |
94,652 |
|
|
Diluted earnings per share |
$ |
2.38 |
|
|
$ |
1.65 |
|
|
|
|
|
|
||||
|
Shares outstanding — diluted |
|
56,127 |
|
|
|
57,486 |
|
|
|
|
|
|
||||
|
ADJUSTMENTS |
|
|
|
||||
|
Inventory step-up amortization (1) |
$ |
— |
|
|
$ |
3,135 |
|
|
Acquisition costs (1) |
|
— |
|
|
|
1,030 |
|
|
Severance and other (1) |
|
— |
|
|
|
5,961 |
|
|
Acquisition amortization of intangibles |
|
19,569 |
|
|
|
19,311 |
|
|
Non-cash gain on minority investment (2) |
|
(22,238 |
) |
|
|
— |
|
|
Total adjustments |
$ |
(2,669 |
) |
|
$ |
29,437 |
|
|
|
|
|
|
||||
|
Adjustments net of tax |
$ |
(632 |
) |
|
$ |
23,844 |
|
|
EPS effect of adjustments |
$ |
(0.01 |
) |
|
$ |
0.41 |
|
|
|
|
|
|
||||
|
NON-GAAP |
|
|
|
||||
|
Adjusted net income (3) |
|
132,750 |
|
|
$ |
118,496 |
|
|
Adjusted earnings per share (4) |
$ |
2.37 |
|
|
$ |
2.06 |
|
|
(1) |
Represents non-recurring cost reduction actions as well as fees and non-cash inventory charges associated with acquisitions. |
|
(2) |
Represents non-cash gain on minority investment accounted for at fair value. |
|
(3) |
Adjusted net income is a non-GAAP measure defined as net income plus tax effected adjustments and other discrete tax items. |
|
(4) |
Adjusted earnings per share is a non-GAAP measure defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items. |
|
RECONCILIATION OF NON-GAAP MEASURES - OPERATING CASH FLOW TO FREE CASH FLOW (Unaudited) (Dollars in thousands)
|
|||||||
|
|
Year to Date |
||||||
|
|
|
|
|
||||
|
Net cash provided by operating activities |
$ |
140,428 |
|
|
$ |
159,122 |
|
|
Additions to property, plant and equipment |
|
(17,513 |
) |
|
|
(21,399 |
) |
|
Free cash flow — year to date (1) |
$ |
122,915 |
|
|
$ |
137,723 |
|
|
|
|
|
|
||||
|
Net income — year to date |
$ |
133,382 |
|
|
$ |
94,652 |
|
|
Non-cash gain on minority investment — after-tax |
|
(16,679 |
) |
|
|
— |
|
|
Net income excluding non-cash gain on minority investment — year to date (2) |
$ |
116,703 |
|
|
$ |
94,652 |
|
|
Free cash flow conversion — year to date (3) |
|
105 |
% |
|
|
146 |
% |
|
(1) |
Free cash flow is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Net cash provided by operating activities minus Additions to property, plant and equipment. |
|
(2) |
Net income excluding non-cash gain on minority investment is a non-GAAP measure used by management as an input to the calculation of Free cash flow conversion and is defined as Net income excluding non-cash gains/losses on minority investment. |
|
(3) |
Free cash flow conversion is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Free cash flow divided by Net income excluding non-cash gain on minority investment. |
|
Management uses certain non-GAAP measures, such as adjusted net income, adjusted EPS and EBITDA, internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260218403558/en/
Vice President
Investor Relations & Corporate Communications
440.204.9985
Lara.Mahoney@nordson.com
Source: